| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | HIPO | Common Stock | Sale | -$213K | -8.05K | -1.57% | $26.52 | 503K | Feb 3, 2025 | See footnote | F1, F2, F3 |
| transaction | HIPO | Common Stock | Sale | -$114K | -4.2K | -0.83% | $27.22 | 499K | Feb 3, 2025 | See footnote | F1, F3, F4 |
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
| Id | Content |
|---|---|
| F1 | Sales were effected pursuant to a Rule 10b5-1 trading plan adopted March 11, 2024. |
| F2 | This transaction was executed in multiple trades at prices ranging from $26.00 to $27.00. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| F3 | Shares held by Assaf and Liron Wand 2014 Revocable Trust. |
| F4 | This transaction was executed in multiple trades at prices ranging from $27.03 to $27.54. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |